AKT1 and cancer: It's also well known that the activity of PTEN antagonizes the PI3K/AKT pathway to suppress cancer cell survival, which means that deficient PTEN expression leads to the PI3K/AKT pathway activation, thereby enhancing cell anti-apoptosis [33–35].